(PLEASE READ)$TEUFF formerly TEU on the NYSE was delisted

New Post Public Reply Private Reply Replies (1) Message Board
MoneyMaker
(PLEASE READ) $TEUFF formerly TEU on the NYSE was delisted due to not maintaining the $15,000,000 Market Cap needed to meet NYSE requirements. Fundamentally TEU is strong. Assets exceed Liabilities by 3.6 Times ($356,000,000 vs $128,000,000 or a Shareholders Equity of $228,000,000, Yah that's AUDITED and REAL and YOURS) . TEU comes with 9 Active & Young Vessels which make them a very attractive Shipping company, one that will draw the eyes of stronger, bigger companies for potential Buyout opportunities based on BOOK VALUE or Better, imo. Now what people are missing is the strength TEU has shown over a 5 Year period where most shipping companies have struggled and or went BK. TEU has had 4 of 5 years of STRONG Revenues between $40 to $60 million Annually and Profitable. 2015 we seen an Impairment which could have been avoided and TEU would have been 5 years Profitable. Here"s what people are missing, being on the National Exchange your company better beat the numbers, the EBITDA and bring shareholder's value, they didn't, so time to delist but only because the Market Cap. So where did they go, OTCQX for a short term. A very respectful exchange. What's that mean for us, it means we get to buy shares at discounted prices because facts are facts, TEU has Massive Upside and Huge SHAREHOLDER'S EQUITY of $228,000,000. They only need the PPS to be higher to get back to a National Exchange which they are applying for and it's the NASDAQ. We are currently at $500,000 Market Cap, Nasdaq requires $15,000,000, other than that they meet the requirements. People don't comprehend Institutions and Investment Bankers CAN"T buy into Penny Stocks, they simply can't. They don't usually buy stock until $5.00 PPS but definitely don't buy OTC stocks, USUALLY. So for us to accumulate these prices are seriously gifts. Especially when the Natural Book Value is $7.11 based on 31.25 million shares. People say but they are going to Reverse Split(1:20 but no more than 1:50), yes they announced it based on a higher PPS and currently the Ratio they stated and the PPS don't allow for the Split to be Practical. Management needs approximately $0.50 to make it work. It's not a split like the crap OTC scam companies, IF they split, it will be their VERY FIRST ONE and ONLY TO UPLIST to the NATIONAL EXCHANGE, the NASDAQ. NO OTHER REASON, NONE. REAL COMPANY, REAL ASSETS, REAL REVENUES and LIMITED LIABILITIES. Those are the REASONS the WORLD BANKS CREDIT SUISSE AG and ABN AMRO N.V. , not Kodiak, have waived payments for 1 year on $131,000,000. They support the BUSINESS PLAN TEU's CEO has offered. This securing NEAR BREAK EVEN COSTS for TEU. That my friends, is HUGE. Still in doubt, well the CEO and the Directors have agreed to Purchase OPEN MARKET SHARES , Approximately 10% by both and an additional 5% by the CEO, that's a huge statement by the company, a huge sign of confidence. Also NOWACKI MICHEALS has INCREASED his holdings to 26% at the time of the Delist. WHY, because he too is confident in the company as well as the fact TEU's SHAREHOLDER EQUITY assures all shareholders of a return whether the GROW as a company or go BK (not happening) lol. WIN WIN. Best of both worlds.

So now it's up to you to decide, is TEUFF a BUY or not....FACTS SHOW TEUFF is GROSSLY UNDERVALUED by a MILE

Quick Math

$228,000,000 Shareholders Equity with 31.2m Shares Outstanding says Book Value is $7.11

or if you think it's diluted, let's go with this scenario (SS has stayed pretty low for 5 Years Only grew by 10m)

$228,000,000 Shareholders Equity with 50m Shares Outstanding says Book Value is $4.56


What is 'Shareholders' Equity'

Shareholders' equity is equal to a firm's total assets minus its total liabilities and is one of the most common financial metrics employed by analysts to determine the financial health of a company. Shareholders' equity represents the net value of a company, or the amount that would be returned to shareholders if all the company's assets were liquidated and all its debts repaid.



Read more: Shareholders' Equity Definition | Investopedia http://www.investopedia.com/terms/s/sharehold...z4CGzPrKOl
Follow us: Investopedia on Facebook
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 12

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 7

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 6

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
First-Time Homeowners: Unseen Pitfalls of Insurance

Updated Category News Views 5

Understanding Homeowners Insurance: Beyond the Basics Most folks diving into homeownership for the first time get caught up in the whirlwind of price tags, loans, and knick-knacks for their new place. Meanwhile, the nitty-gritty of homeowners insurance often gets tossed to the side. But take it from a weary watchdog of financial storms—it’s those details in the policy...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 3

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 3

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading

Top 5 Most Recently Viewed Articles

Enanta Pharmaceuticals Highlights Fiscal Q1 2025 Performance

Updated Category News Views 188

Enanta Pharmaceuticals Reports Financial Highlights for Q1 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology firm, has revealed its financial results for the first fiscal quarter ending December 31, 2024. This quarter is seen as a crucial period for the company as it expands its innovative drug portfolio targeting viral and immunological...

Continue Reading
Friedman Industries Reports Impressive First Quarter Growth

Updated Category News Views 98

Friedman Industries Reports Significant First Quarter Growth Friedman Industries, Incorporated (NASDAQ/GS: FRD) has announced remarkable results for the first quarter of the fiscal year, showcasing a strong performance that has positioned the company favorably in the steel manufacturing sector. The results released highlight not only the growth in earnings but also an...

Continue Reading
From Doubt to Delicious: The Rise of Raising Cane's

Updated Category News Views 308

Overcoming Doubt: The Birth of Raising Cane's The journey of Raising Cane's is not just about chicken fingers; it's a story of perseverance. Founded by Todd Graves, the chain has become a testament to how challenges can fuel passion and success. Graves faced significant skepticism from those who thought the concept was flawed due to its limited menu. Motivation Behind...

Continue Reading
Understanding Japan's Impact on US Tech Stock Dynamics

Updated Category News Views 371

The Influence of Japan's Real Rates on US Markets The current landscape of the S&P 500 bull market has been subject to various influences, and surprisingly, one of the most significant factors is not a domestic recession in the US but rather Japan's extraordinarily negative real interest rates compared to those in the US. This insightful perspective comes from BCA...

Continue Reading
Ocean Ledger Secures Funding to Enhance Coastal Risk Solutions

Updated Category News Views 171

Ocean Ledger Secures Funding for Coastal Risk Management Ocean Ledger, a promising geospatial analytics startup, has recently completed a successful funding round, securing $900K to enhance its capabilities in coastal risk management. This investment is poised to support the development of innovative solutions aimed at forecasting coastal risks, benefitting various...

Continue Reading